GCP
AHPI

GSA Capital Partners’s Allied Healthcare Products AHPI Stock Holding History

GSA Capital Partners’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,414
Closed -$81K – 1891
2021
Q2 		$81K Buy
19,414
+2,150
+12% +$9.16K 0.01% 1261
2021
Q1 		$82K Buy
+17,264
New +$98.6K 0.01% 1010

Other funds holding AHPI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GSA Capital Partners's AHPI Position: Q3 2021 in Review

GSA Capital Partners sold out of Allied Healthcare Products (AHPI) in Q3 2021, closing a stake of 19,414 shares — an estimated $81K sold.

GSA Capital Partners first reported a position in AHPI in Q1 2021 and held it in 2 quarters. The position peaked at $82K in Q1 2021. 13 funds tracked by Wall St. Rank hold AHPI as of Q3 2021.

  • GSA Capital Partners reported no remaining Allied Healthcare Products position as of Q3 2021 after selling out during the quarter.
  • GSA Capital Partners sold 19,414 Allied Healthcare Products shares in Q3 2021, an estimated $81K.
  • GSA Capital Partners first reported a position in Allied Healthcare Products in Q1 2021 and held it in 2 quarters.
  • GSA Capital Partners's Allied Healthcare Products position peaked at $82K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q3 2021.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.